Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
Eva L. Feldman, Masha G. Savelieff, Salim S. Hayek, et al.
Diabetes (2020) Vol. 69, Iss. 12, pp. 2549-2565
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Kanyin Liane Ong, Lauryn K Stafford, Susan A. McLaughlin, et al.
The Lancet (2023) Vol. 402, Iss. 10397, pp. 203-234
Open Access | Times Cited: 1872
Post COVID-19 Syndrome (“Long COVID”) and Diabetes: Challenges in Diagnosis and Management
Arkiath Veettil Raveendran, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 5, pp. 102235-102235
Open Access | Times Cited: 138
Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
Raffaele Izzo, Valentina Trimarco, Pasquale Mone, et al.
Pharmacological Research (2022) Vol. 183, pp. 106360-106360
Open Access | Times Cited: 75
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 72
COVID-19 Pandemic as Risk Factors for Excessive Weight Gain in Pediatrics: The Role of Changes in Nutrition Behavior. A Narrative Review
Hellas Cena, Lauren Fiechtner, Alessandra Vincenti, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4255-4255
Open Access | Times Cited: 78
Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic
Edward W. Gregg, Marisa K. Sophiea, Misghina Weldegiorgis
Diabetes Care (2021) Vol. 44, Iss. 9, pp. 1916-1923
Open Access | Times Cited: 71
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
Alexi Vasbinder, Élizabeth Anderson, Husam Shadid, et al.
Diabetes Care (2022) Vol. 45, Iss. 3, pp. 692-700
Open Access | Times Cited: 62
Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity
Andreea Buicu, Simona Cernea, Imre Benedek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1545-1545
Open Access | Times Cited: 59
Bioactive compounds from Polygonatum genus as anti-diabetic agents with future perspectives
Yan Shi, Dun Si, Donghong Chen, et al.
Food Chemistry (2022) Vol. 408, pp. 135183-135183
Open Access | Times Cited: 57
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis
Honghao Lai, Manli Yang, Mingyao Sun, et al.
Metabolism (2022) Vol. 137, pp. 155330-155330
Open Access | Times Cited: 40
Diabetes and COVID19: a bidirectional relationship
Ranjit Unnikrishnan, Anoop Misra
Nutrition and Diabetes (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 54
Diabetes and the Risk of Long-term Post-COVID Symptoms
César Fernández‐de‐las‐Peñas, Carlos Guijarro, Juan Torres‐Macho, et al.
Diabetes (2021) Vol. 70, Iss. 12, pp. 2917-2921
Open Access | Times Cited: 53
Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19
Yunlong Ma, Yukuan Huang, Sen Zhao, et al.
Human Molecular Genetics (2021) Vol. 30, Iss. 13, pp. 1247-1258
Open Access | Times Cited: 43
Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes—Implications for Retinopathy
Lingli Zhou, Zhenhua Xu, James Guerra, et al.
Investigative Ophthalmology & Visual Science (2021) Vol. 62, Iss. 7, pp. 6-6
Open Access | Times Cited: 43
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
Clifford J. Bailey, Mike Gwilt
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study
Raffaele Izzo, Daniela Pacella, Valentina Trimarco, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102345-102345
Open Access | Times Cited: 19
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table
Francesco Cosentino, Subodh Verma, Philip Ambery, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4141-4156
Open Access | Times Cited: 18
Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 1, pp. 34-39
Open Access | Times Cited: 8
Editorial: Obesity, metabolic phenotypes and COVID-19
Despina Sanoudou, Michael A. Hill, Matthew J. Belanger, et al.
Metabolism (2022) Vol. 128, pp. 155121-155121
Open Access | Times Cited: 27
The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and Outcomes
Mikhail M. Minashkin, Nataliya Yu. Grigortsevich, Anna S. Kamaeva, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 549-549
Open Access | Times Cited: 27
Long COVID-19
Isabel Rodríguez-Sánchez, Leocadio Rodrı́guez-Mañas, Olga Laosa
Clinics in Geriatric Medicine (2022) Vol. 38, Iss. 3, pp. 533-544
Open Access | Times Cited: 27
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection
Masha G. Savelieff, Eva L. Feldman, Amro Stino
Neurobiology of Disease (2022) Vol. 168, pp. 105715-105715
Open Access | Times Cited: 25
The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes
Kamlesh Khunti, Eva L. Feldman, Neda Laiteerapong, et al.
Diabetes Care (2022) Vol. 46, Iss. 2, pp. 228-236
Open Access | Times Cited: 25
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 16
A new series of hydrazones as small‐molecule aldose reductase inhibitors
Mehlika Dilek Altıntop, Yeliz Demir, Cüneyt Türkeş, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 4
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top